| Armen Aghabegian, PA | |
|
660 W Broadway, Glendale, CA 91204-1008 | |
| (818) 243-9600 | |
| (818) 243-9605 |
| Full Name | Armen Aghabegian |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 20 Years |
| Location | 660 W Broadway, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144334723 | NPI | - | NPPES |
| PA17744 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | PA17744 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Hospitals that manage the highest volume of deceased organ donors are 52 percent more likely to recover an above-average number of transplantable organs per donor compared with low-volume hospitals, according to results from a new study conducted across three U.S. donation regions.
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.
Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.
According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Armen Aghabegian, PA 660 W Broadway, Glendale, CA 91204-1008 Ph: (818) 243-9600 | Armen Aghabegian, PA 660 W Broadway, Glendale, CA 91204-1008 Ph: (818) 243-9600 |
News Archive
Hospitals that manage the highest volume of deceased organ donors are 52 percent more likely to recover an above-average number of transplantable organs per donor compared with low-volume hospitals, according to results from a new study conducted across three U.S. donation regions.
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.
Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.
According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease.
› Verified 9 days ago
Tigran Khachatryan, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 660 W Broadway, Glendale, CA 91204 Phone: 818-243-9600 | |
Dr. Jean-pierre E Antaki, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #105, Glendale, CA 91205 Phone: 818-242-5299 Fax: 818-637-7607 | |
Dr. Ellie Bloomfield, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1808 Verdugo Blvd, Suite 403, Glendale, CA 91208 Phone: 818-790-7098 Fax: 818-790-7099 | |
Edgar H Aleman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 435 Arden Ave, 410, Glendale, CA 91203 Phone: 818-242-4191 Fax: 818-242-4811 | |
Michael Eugene Klein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1818 Verdugo Blvd, #300, Glendale, CA 91208 Phone: 818-952-5332 Fax: 818-790-6830 | |
Alen Mirzaian, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1818 Verdugo Blvd Ste 401, Glendale, CA 91208 Phone: 818-790-1145 | |
Dr. Thomas Yarger Pocock, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1809 Verdugo Blvd, #200, Glendale, CA 91208 Phone: 818-790-6700 Fax: 818-790-2816 |